6 Matching Annotations
  1. Last 7 days
  2. aacrjournals.org aacrjournals.org
    Milademetan in advanced solid tumors with MDM2 amplification and wild-type TP53: pre-clinical and phase 2 clinical trial results
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    aacrjournals.org/clincancerres/article/31/20/4255/766076/Milademetan-in-Advanced-Solid-Tumors-with-MDM2
  3. Nov 2023
  4. www.mdpi.com www.mdpi.com
    PDE3A Is a Highly Expressed Therapy Target in Myxoid Liposarcoma
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    mdpi.com/2072-6694/15/22/5308
  5. Aug 2023
  6. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10391328/
  7. Jul 2023
  8. 52.53.155.43 52.53.155.43
    can-22-3173-html.html
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/7a07162d3285902b20a1a359628fdd8826284ee8/can-22-3173-html.html
  9. Jun 2023
  10. 52.53.155.43 52.53.155.43
    can-22-3173-html.html
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/7a07162d3285902b20a1a359628fdd8826284ee8/can-22-3173-html.html
  11. Mar 2023
  12. www.sciencedirect.com www.sciencedirect.com
    FAM193A is a positive regulator of p53 activity
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2211124723002413